From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

CBRN Medical Countermeasures Clinical Studies Network

by Global Biodefense Staff
March 18, 2013

The Biomedical Advanced Research and Development Authority (BARDA) is seeking to establish a Medical Countermeasure Clinical Studies Network composed of contract research organizations to facilitate vaccine and therapeutic development for pandemic influenzas and chemical, biological, nuclear and radiological (CBRN) threats. 

The proposed contracts will establish a network of providers to satisfy the clinical service requirements of BARDA and complement efforts of the National Institute of Allergy and Infectious Diseases (NIAID). 

Awardees will provide clinical research services including full service capabilities to execute a clinical trial as a service to BARDA. These studies may be Phase 1, 2, 3, or 4 or combinations of these Phases. Clinical research services may include, but are not limited to the following components:

Contracts may also contain preparedness and response task components that require contractors to be at the ready for urgent clinical trials in the case of a public health medical emergency. 

“Awardees will support targeted clinical studies relevant to BARDA’s vision to create a nation with the capability to respond quickly and effectively to deliberate, natural and emerging threats by providing a range of clinical study services that can be used by BARDA and development partners of BARDA,” states the announcement.

An official request for proposals is estimated to begin on March 30, 2013, with proposals being due May 14, 2013.  Multiple awards may result from the solicitation with an estimated award date of September 2013. 

Further details are available under Solicitation Number: RFP-13-100-SOL-00008.

From Our Partners
Tags: ASPRBARDAHHSRequest for ProposalsVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC